Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PP13 and Doppler for Preeclampsia Risk Prediction
NCT00928213Phase 3Unknown
- Sponsor
- Ben-Gurion University of the Negev
- Start
- Aug 2009
- Primary completion
- Dec 2010
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of progesterone, enoxaparin in preeclampsia, sponsored by Ben-Gurion University of the Negev. Status: unknown.
02
Drugs
progesteroneenoxaparin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT00928213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00928213.